FDA Approved: DIHYDROERGOTAMINE MESYLATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved Hikma Pharmaceuticals USA Inc.'s supplemental application for dihydroergotamine mesylate (ANDA 040453).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Dihydroergotamine mesylate (Dihydroergotamine Mesylate)

Snippet

SUPPL AP for DIHYDROERGOTAMINE MESYLATE (DIHYDROERGOTAMINE MESYLATE)